scholarly article | Q13442814 |
P50 | author | Lori S Lutzke | Q115607420 |
Ganapathy A Prasad | Q115607457 | ||
Lynn S Borkenhagen | Q115607460 | ||
Louis-Michel Wongkeesong | Q115607462 | ||
Kelly T Dunagan | Q115607463 | ||
P2093 | author name string | Navtej S Buttar | |
Kenneth K Wang | |||
Dennis A Wigle | |||
Tsung Teh Wu | |||
P2860 | cites work | A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 |
A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data | Q31156910 | ||
Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results | Q33187809 | ||
Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy | Q33320089 | ||
Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation | Q34238141 | ||
Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study | Q34238147 | ||
Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus | Q35689634 | ||
Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia | Q36950822 | ||
Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus | Q37106233 | ||
Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus | Q37106236 | ||
Detection and endoscopic therapy of early esophageal adenocarcinoma. | Q37214402 | ||
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group | Q39605645 | ||
Minimally invasive esophagectomy: outcomes in 222 patients. | Q42610353 | ||
Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia | Q44201647 | ||
Outcomes after transhiatal and transthoracic esophagectomy for cancer | Q44448365 | ||
Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). | Q44450100 | ||
Hospital volume and surgical mortality in the United States. | Q44464097 | ||
Multiband mucosectomy for endoscopic resection of Barrett's esophagus: feasibility study with matched historical controls. | Q51050986 | ||
Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus. | Q53255484 | ||
Metachronous esophageal cancer and colon cancer treated by endoscopic mucosal resection. | Q53554037 | ||
Minimally invasive esophagectomy. | Q53903821 | ||
Esophageal Cancer | Q56209683 | ||
Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection | Q58484694 | ||
Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques | Q74599441 | ||
Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia | Q79658658 | ||
Risk factors for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection | Q79658669 | ||
Initial experience with minimally invasive Ivor Lewis esophagectomy | Q79972515 | ||
Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma | Q80775144 | ||
Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma | Q80802072 | ||
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer | Q80807888 | ||
Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus | Q81226171 | ||
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
Minimally invasive resection and mechanical cervical esophagogastric anastomotic techniques in the management of esophageal cancer | Q81384517 | ||
Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection | Q81786429 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adenocarcinoma | Q356033 |
Barrett's esophagus | Q808892 | ||
P304 | page(s) | 815-823 | |
P577 | publication date | 2009-06-12 | |
P1433 | published in | Gastroenterology | Q4039279 |
P1476 | title | Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus | |
P478 | volume | 137 |
Q38634473 | A Systematic Review of Esophageal MicroRNA Markers for Diagnosis and Monitoring of Barrett's Esophagus |
Q37653058 | A survey of expert follow-up practices after successful endoscopic eradication therapy for Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma |
Q26781194 | Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma |
Q35673305 | American Gastroenterological Association technical review on the management of Barrett's esophagus |
Q50712570 | Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognostication. |
Q42780178 | Assessment of the diagnostic performance and interobserver variability of endocytoscopy in Barrett's esophagus: a pilot ex-vivo study |
Q38018063 | Barrett's Esophagus: A Review of Biology and Therapeutic Approaches. |
Q26751171 | Barrett's esophagus in 2016: From pathophysiology to treatment |
Q38206691 | Barrett's esophagus: review of diagnosis and treatment |
Q58484642 | Barrett's esophagus: treatments of adenocarcinomas I |
Q38608994 | Barrett's oesophagus: how should we manage it? |
Q41873359 | Biodegradable esophageal stent placement does not prevent high-grade stricture formation after circumferential mucosal resection in a porcine model |
Q34380645 | British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus |
Q35579540 | Clinical Efficacy of Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction |
Q35107000 | Clinical and histologic determinants of mortality for patients with Barrett's esophagus-related T1 esophageal adenocarcinoma |
Q44163041 | Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma. |
Q30579739 | Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study |
Q58563959 | Comparison of the short-term and long-term outcomes of surgical treatment versus endoscopic treatment for early esophageal squamous cell neoplasia larger than 2 cm: a retrospective study |
Q38005810 | Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process |
Q38679483 | Current and future treatment options for esophageal cancer in the elderly |
Q47848689 | Developments in optical imaging for gastrointestinal surgery. |
Q55177484 | Diagnosis and treatment of superficial esophageal cancer. |
Q37172054 | Early Esophageal Cancer Specific Survival Is Unaffected by Anatomical Location of Tumor: A Population-Based Study |
Q38675582 | Emerging Concepts for the Endoscopic Management of Superficial Esophageal Adenocarcinoma. |
Q38670180 | Endoluminal therapies for Barrett's esophagus |
Q47744493 | Endoscopic Treatment Versus Esophagectomy for Early-Stage Esophageal Cancer: a Population-Based Study Using Propensity Score Matching |
Q90602522 | Endoscopic Treatment of Early-Stage Esophageal Cancer |
Q37787343 | Endoscopic Ultrasound Does Not Accurately Stage Early Adenocarcinoma or High-Grade Dysplasia of the Esophagus |
Q26863367 | Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review |
Q38270440 | Endoscopic approaches for early-stage esophageal cancer: current options |
Q37926908 | Endoscopic management of Barrett esophagus |
Q84660676 | Endoscopic management of early esophageal neoplasia: an emerging standard |
Q33928678 | Endoscopic methods in the treatment of early-stage esophageal cancer |
Q30474279 | Endoscopic mucosal resection in the management of esophageal neoplasia: current status and future directions |
Q35129311 | Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy |
Q26823702 | Endoscopic submucosal dissection for superficial Barrett's esophageal cancer in the Japanese state and perspective |
Q38216027 | Endoscopic therapies for Barrett's neoplasia |
Q41906748 | Epithelial mesenchymal transition and cancer stem cells in esophageal adenocarcinoma originating from Barrett's esophagus |
Q33680811 | Esophageal cancer: staging system and guidelines for staging and treatment |
Q88022225 | Evolution in the Treatment of Esophageal Disease at a Single Academic Institution: 2004-2013 |
Q91800352 | Extracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell Phenotype |
Q36348420 | Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett's esophagus |
Q37781292 | Guidelines for surgical treatment of gastroesophageal reflux disease |
Q37997343 | High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of endoscopic eradication therapy |
Q33786336 | History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus |
Q58752113 | Impact of the development of an endoscopic eradication program for Barrett's esophagus with high grade dysplasia or early adenocarcinoma on the frequency of surgery |
Q27311238 | In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video). |
Q57902278 | Long-Term Outcome and Metastatic Risk After Endoscopic Resection of Superficial Esophageal Squamous Cell Carcinoma |
Q52880496 | Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resection. |
Q38111974 | Management controversies in Barrett's oesophagus |
Q38078005 | Management of complications associated with endoscopic submucosal dissection/ endoscopic mucosal resection for esophageal cancer |
Q53076121 | Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease. |
Q48065525 | MicroRNA Expression Signatures During Malignant Progression From Barrett's Esophagus |
Q41696429 | MicroRNA Expression can be a Promising Strategy for the Detection of Barrett's Esophagus: A Pilot Study |
Q37988359 | MicroRNA and its roles in esophageal cancer. |
Q38626333 | Multidisciplinary treatment of T1a adenocarcinoma in Barrett's esophagus: contemporary comparison of endoscopic and surgical treatment in physiologically fit patients. |
Q37783343 | New endoscopic and surgical treatment options for early esophageal adenocarcinoma. |
Q38220816 | Operable gastro-oesophageal junctional adenocarcinoma: Where to next? |
Q37763082 | Optimal endoluminal treatment of Barrett's esophagus: integrating novel strategies into clinical practice |
Q40071822 | Outcomes after endoscopic versus surgical therapy for early esophageal cancers in an older population. |
Q38791447 | Outcomes of Surgical Resection of T1bN0 Esophageal Cancer and Assessment of Endoscopic Mucosal Resection for Identifying Low-Risk Cancers Appropriate for Endoscopic Therapy |
Q88528275 | Point-Counterpoint: Screening and Surveillance for Barrett's Esophagus, Is It Worthwhile? |
Q38936662 | Population-based cohort study of the management and survival of patients with early-stage oesophageal adenocarcinoma in England |
Q38868480 | Predictors of esophageal stricture formation post endoscopic mucosal resection |
Q52656900 | Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy-A propensity score-matched comparison. |
Q64897160 | Prognostic significance of baseline fatigue for overall survival: A patient-level meta-analysis of 43 oncology clinical trials with 3915 patients. |
Q44529270 | Randomized study of two endo-knives for endoscopic submucosal dissection of esophageal cancer. |
Q50057605 | Recent Advances in Screening for Barrett's Esophagus. |
Q26849652 | Recent developments in esophageal adenocarcinoma |
Q38014492 | Reducing complications in upper gastrointestinal endoscopy |
Q34777727 | Reflux and Barrett's disease. |
Q90049366 | Relationship of lymphovascular invasion with lymph node metastasis and prognosis in superficial esophageal carcinoma: systematic review and meta-analysis |
Q53791566 | Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. |
Q58707792 | Role of endoscopic therapy in early esophageal cancer |
Q36047111 | SURGERY VERSUS ENDOSCOPIC THERAPIES FOR EARLY CANCER AND HIGH-GRADE DYSPLASIA IN THE ESOPHAGUS: a systematic review |
Q45066783 | Safety and efficacy of endoscopic spray cryotherapy for esophageal cancer |
Q37274334 | Safety of endoscopic mucosal resection for Barrett's esophagus |
Q30514061 | Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus |
Q42287321 | Saudi Oncology Society clinical management guideline series. Esophageal cancer 2014. |
Q39171528 | Screening and Preventive Strategies in Esophagogastric Cancer |
Q34624586 | Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions |
Q37995081 | Screening for oesophageal cancer. |
Q38940521 | Staging Early Esophageal Cancer |
Q48687568 | Surgical Treatment of High-Grade Dysplasia and Early Esophageal Cancer |
Q37469145 | Survival of patients with superficial esophageal adenocarcinoma after endoscopic treatment vs surgery |
Q38119219 | T1 esophageal cancer, request an endoscopic mucosal resection (EMR) for in-depth review |
Q37488137 | The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma |
Q33692737 | The risk of endoscopic mucosal resection in the setting of clopidogrel use. |
Q27027036 | The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review |
Q38237038 | The surgeon’s perspective on oesophageal disease, and what it means to pathologists |
Q38098748 | Tissue engineering and regenerative medicine as applied to the gastrointestinal tract |
Q39797954 | Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement |
Q61804242 | Treatment disparities affect outcomes for patients with stage I esophageal cancer: a national cancer data base analysis |
Q37638575 | Treatment modalities for T1N0 esophageal cancers: a comparative analysis of local therapy versus surgical resection |
Q38097342 | Treatments for esophageal cancer: a review |
Q26751160 | Update on management of Barrett's esophagus |
Q89425053 | Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus |
Q52916114 | Utility of dysphagia grade in predicting endoscopic ultrasound T-stage of non-metastatic esophageal cancer. |
Q38868367 | When is pre-emptive treatment necessary after endoscopic mucosal resection of early esophageal neoplasm? |
Q87464661 | [Barrett's esophagus and carcinoma: Recommendations of the S2k guideline 2014 and the S3 guideline 2015] |
Q53095026 | [Barrett's esophagus. An update]. |
Q84009951 | [Early esophageal cancer: pro-endoscopic resection] |
Q83245694 | [Endoscopic and surgical resection of mucosal adenocarcinoma in Barrett's esophagus : Comparison at two high-volume centers] |
Search more.